DocumentsDate added
Original article:
1Akshay M Daga,*2Pankaj J Akhare,3Ajay S Saxena,4Mohit B Zamad,5Mohsin A Quazi & 6RidhiShri P Akhare
Affiliation:-
1Associate Professor,Department of Oral and Maxillofacial Surgery,V.S.P.M’s Dental College and Research Center,Digdoh Hills, Hingna,Nagpur – 440019. Maharashtra. India.
*2Associate Professor,Department of Orthodontics & Dentofacial Orthopedics,V.S.P.M’s Dental College and Research Center,Digdoh Hills, Hingna,Nagpur – 440019. Maharashtra. India.
3Associate Professor,Department of Conservative & Endodontics,SPDC Dental College and Research Center,DMIMMS, Sawangi (Meghe), Wardha.Maharashtra. India.
4 3rd Year PG,Department of Oral and Maxillofacial Surgery,V.S.P.M’s Dental College and Research Center,Digdoh Hills, Hingna,Nagpur – 440019. Maharashtra. India.
5 2nd Year PG,Department of Prostthetic & Implantology,S K Dental College and Research Center,Hingna,Nagpur – 440019.Maharashtra.India.
6 BDS,92, New Jagruti Colony,Near Friends Colony,Katol Road,Nagpur–440013.Maharashtra. India.
Abstract:
Background: Cleft surgeries in the developing world serve as not only aesthetic and functional ones but, in some cases, as life saving operations too.
Aim: To evaluate the level of awareness of cleft patients with regards to their defect and relate it to their quality of life taking internationally approved and local factors into consideration.
Settings and Design:
Random study 123 patients completed the MOS short form – 36 questionnaire to evaluate the health related quality of life along with a few other questions. The aesthetic, functional and psychological outcomes were assessed on a visual analog scale.
Results: The main cause for clefts was considered to be god’s will. 29% of the patients were not allowed to draw water from the local well and 38% were not allowed to join school before the surgery, while post surgically only 6% had the same problems. The health related quality of life questionnaire demonstrated higher scores in all subsets under the mental health criteria after cleft surgeries.
Conclusion: Where myths and beliefs are still present, the surgery not only improves the facial appearance and function, but also helps the patient to be inculcated back into the society.
Key Words: Cleft Lip and palate, Health related quality of life, Myths and beliefs, Psychological aspects, Short form questionnaire.
References:
1.Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969;62:989–93.
2.Jenkinson C, Wright L, Coulter A. Criterion validity and reliability of the SF- 36 in a population sample. Qual Life Res. 1994; 3:7–12.
3.Noar JH. Questionnaire survey of attitudes and concerns of patients with cleft lip and palate and their parents. Cleft Palate Craniofac J. 1991;28:279–284.
4.Fadekemi O. Oginni. Knowledge and Cultural Beliefs about the Etiology and Management of Orofacial Clefts in Nigeria's Major Ethnic Groups. The Cleft Palate-Craniofacial Journal: 2010 July;47(4):327-34.
5.Vanderberg. Perceptions, Expectations, and Reactions to Cleft Lip and Palate Surgery in Native Populations: A Pilot Study in Rural India. The Cleft Palate-Craniofacial Journal: September 2005; 42(5): 560-4.
6.Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T Et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160–4.
7.Ramstad , Ottem E – Psychosocial adjustments in south African adults who had undergone standardized treatment of complete cleft lip and palate. Scand J Plast Reconstr Surg hand Surg. 1995 Dec;29(4):329-36.
8.Agneta Marcusson – Quality of life in adults with repaired complete cleft lip and palate. Celft palate Craniofac J. 2001;38(4):379-85.
9.Kapp K. Self concept of the cleft lip and or palate child. Cleft Palate J. 1979; 16:171–6.
10.Clifford E, Crocker EC, Pope BA. Psychological findings in the adulthood of 98 cleft lip-palate children. Plast Reconstr Surg. 1972;50:234–7.
11.Cheung LK, Loh JS - Psychological profile of Chinese with cleft lip and palate deformities. Cleft Palate Craniofac J, 2007 Jan;44(1):79-86.
12.McWilliams B J, Paradise L P. Educational, occupational, and marital status of cleft palate adults. Cleft Palate Journal 1979;10: 223–9.
13.Peter J P, Chinsky R.R, Fisher M J. Sociological aspects of cleft palate adults: 3. Vocational and economic aspects. Cleft Palate Journal.1975;12:193–9.
14.Tyl J, Dytrych Z, Helclová H, Scüller V, Matĕjcĕk Z, The psychosocial effects of cleft lip and palate: a systematic Review. European Journal of Orthodontics.2005; 27:274–85.
15.Lockhardt et al, 'Outlook': A Psychological Service for Children with a Different Appearance Clin Child Psychol Psychiatry.2006; 11: 431- 43.
16.Bjornsson A, Agustsdottir S. A psychosocial study of Icelandic individuals with cleft lip or cleft lip and palate. Cleft Palate J. 1987;24:152–7.
17.Sinko K.Jagsch R, Prechtl V, Watzinger F, Hollmann K, Baumann A. Evaluation of Esthetic, Functional, and Quality-of-Life Outcome in Adult Cleft Lip and Palate Patients. Cleft Palate–Craniofacial Journal. 2005 july; 42 ( 4):355-6.
Article citation:-
Akhare et al. Cleft lip and palate- Improving lives through awareness. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) 2013, June; 31(31): 1159-1163.
Copyright © 2013 Akhare et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original article:-
Maninder Karan*1, Kawal Preet 2 & Karan Vasisht3
M. Pharm., Ph. D.*1, M. Pharm.2, M. Pharm., Ph. D.3
University Institute of Pharmaceutical Sciences–UGC Centre for Advanced Studies, Panjab University, Chandigarh 160014, India.
Abstract:-
The present study assessed topical anti-inflammatory activity of different species of an indigenous drug Barleria against croton oil induced oedema in female rats. Seven different extracts viz., mother extract (methanolic, ME, prepared by maceration), hexane (HE), chloroform (CE), ethyl acetate (EAE), butanol (BE) and left aqueous (LAE) extracts obtained after partitioning of ME and total aqueous extract (TAE, prepared by maceration) of each Barleria spp. were evaluated at 200 and 400 mg/ml prepared in croton oil solution using ibuprofen as a standard. The maximum effect was observed at a dose of 200 mg/ml for all the extracts of both the species and chloroform extract of B. prionitis showed the best topical activity with 88.31 per cent inhibition of ear oedema.
Key Words: - Barleria prionitis, B. cristata, Anti-inflammatory, Topical model.
References:-
1.Robins A, Cotrans K. Acute and chronic inflammation. In: Giltman LI. Inflammation, pathologic basis of disease. VIII ed: Elsevier publisher, Chicago; 2009. p. 43-77.
2.Mitchell RN, Cotron RS. Robinson’s basic pathology, VII ed: Harcourt (India) Pvt Ltd., New Delhi; 2000. p. 33.
3.Vogel GH. Analgesic, anti-inflammatory and anti-pyretic activity. In: Vogel WH, Scholkens, BA, Sandow, J, Muller, G and Vogel, WF. Drug Discovery and Evaluation Pharmacological Assays. II ed: Springer publications, Germany; 2002. p. 725-71.
4.Goyal R, Sharma P, Singh M. Possible attenuation of nitric oxide expression in anti-inflammatory effect of Ziziphus jujuba in rat. J Nat Med. 2011; 65:514-8.
5.Tripathi KD. Prostaglandins, leukotrienes (eicosanoids) and platelet activating factor. In: Essentials of medical pharmacology. IV ed: Jaypee publishers, New Delhi; 1999. p. 210-21.
6.Hecker M, Foegh ML, Ramwell PW. The eicosanoids: prostaglandins, thromboxanes, leukotrienes and related compounds. In: Katzung BG. Basics and clinical pharmacology. XI ed: Appleton and Lange, Paramount publishers; 2009. p. 313-29.
7.Goodman A, Gillman, L. Autocoids: The theory of inflammation. In: Brunton L, Parker, K, Blumenthal, D, Buxton, L. Manual of Pharmacology and Therapeutics. III ed: Tata McGraw Hill Companies, New Delhi; 2008. p. 4301.
8.Sautebin L, Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. Fitoterapia. 2000; 71:S48–S57.
9.Balkwill MJ, Balkwill K. A preliminary analysis of distribution pattern in a large, pantropical genus, Barleria L. (Acanthaceae). J Biogeogr. 1998; 25:95-110.
10.Makholela T, Bank H, Balkwill K. A preliminary study of allozyme variation in three rare and restricted endemic Barleria greenii (Acanthaceae) populations. Biochem Syst Ecol. 2003; 31:141-54.
11.Anonymous. The Wealth of India, A Dictionary of Indian Raw Materials and Industrial Products. Council of Scientific and Industrial Research, New Delhi; 1948. Vol 1, p 158.
12.Hooker JD. The Flora of British India The authority of the secretary of state for India and council. Reeve and Co. Ltd; 1885. Vol IV, p. 486.
13.Shendage SM, Yadav SR. Revision of the genus, Barleria (Acanthaceae) in India. Rheedea. 2010; 20: 81-130.
14.Anonymous. The Ayurvedic Pharmacopoeia of India, Govt. of India, Ministry of Health and Family Welfare Dept of Indian System of Medicine and Homeopathy. Vol. III, Part I. I ed; 2001. p. 165-8.
15.Borthakur SK, Nath K, Gogoi P. Herbal remedies of the Nepalese of Assam. Fitoterapia. 1996; LXVII(3): 231-37.
16.Kirtikar KR, Basu BD, editors. Indian Medicinal Plants. Council of Scientific and Industrial Research, New Delhi; II ed, 1956. p. 1876-88.
17.Anonymous. Reviews on Indian Medicinal Plants. Indian Council of Medical Research, New Delhi; 2004. p. 63-82.
18.Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants New Delhi; 1956. p. 32-3.
19.Jain SP, Puri HS. Ethnomedicinal plants of Jaunsar-Bawar hills, Uttar Pradesh, India. J Ethnopharmacol. 1984; 12:215.
20.Pandey G. Dravyaguna Vijnana, Materia Medica Vegetable Drugs: Chaukhambha Orientalia, Part III (P-Y), Varanasi; 2004. 279-86.
21.Shastry JLN. Dravyaguna Vijnana, Study of Essential Medicinal Plants in Ayurveda. Vol II. II ed: Chaukhambha Orientalia,Varanasi; 2005. p. 884-85.
22.Banerjee D, Maji AK, Mahapatra S, Banerji P. Barleria prionitis Linn.: A review of its traditional uses, phytochemistry, pharmacology and toxicity. Res J Phytochem. 2012; 6(2):31-41.
23.Singh B, Bani S, Gupta DK, Chandan BK, Kaul A. Antiinflammatory activity of ‘TAF’ an active fraction from the plant Barleria prionitis Linn. J Ethnopharmacol. 2000; 85: 187-93.
24.Karan M, Kaur I, Chopra D, Vasisht K, inventors; Anti-inflammatory activity of the iridoid glycosides Published on 9.4.2010 with Indian Patent Application no 2182/DEL/2008.
25.Khadse CD, Kakde RB. Antiinflammatory activity of aqueous extract fractions of Barleria prionitis L. roots. Asian J Plant Sci Res. 2011; 1(2):63-8.
26.Jaiswal SK, Dubey MK, Das S, Verma AR, Vijaykumar M, Rao CV. Evaluation of flower of Barleria prionitis for anti-inflammatory and anti-nociceptive activity. Int J Pharm Bio Sci. 2010; 6(2):1-10.
27.Lehra KS, Chawla AS, Maninder KV. Chemical investigation and anti-inflammatory activity of Barleria prionitis. Indian J Nat Prod 2010; 26 (2):3-7.
28.Gambhire NM, Wankhede SS, Juvekar RA. Anti-inflammatory activity of fractions of the Barleria cristata leaves extract. Pharmacology online 2009; 2:1014-24.
29.Gambhire M, Juvekar A, Wankhede S. Evaluation of anti-inflammatory activity of methanol extract of Barleria cristata leaves by in vivo and in vitro methods. Internet J Pharmacol. 2009; 7(1).
30.Ammo SO, Finnie JF, Staden JV. In vitro pharmacological evaluation of three Barleria species. J Ethnopharmacol. 2009; 121:274-7.
31.Kawal P, Vasisht K, Karan M. Acute and sub-acute anti-inflammatory evaluation with chemical studies on two species of an indigenous drug ‘Barleria.’ J Pharm Biomed Sci. (communicated).
32.Kulkarni SK. Practical Pharmacology and Clinical Pharmacy. Vallabh Publications, New Delhi; I ed: 2008. p. 166-69.
33.Tubaro A, Delbello G, Zilli C, Della LR. The Croton oil ear test revisited. Agents Actions. 1985; 17:347-9.
34.Winter CA, Risley EA, Nuss GW. Croton oil -induced ear oedema in rat as an assay for anti-inflammatory drugs. Biol exp protocols 1998; 59:544-9.
35.Leung DYM, Harbeck R, Bina P, Reiser RF, Yang E, Norris DA, Hanifin JM, Sampson HA. Presence of IgE antibodies to Staphylococcal exotoxins on the skin of patients with atopic dermatitis. J. Clin. Invest. 1993; 92:1374-80.
Article citation:-
Maninder Karan, Preet Kawal & Karan Vasisht. Topical anti-inflammatory studies on Barleria prionitis and B. cristata. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) 2013 June; 31(31): 1164-1169.
Copyright © 2013 Maninder Karan, Kawal Preet & Karan Vasisht. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Original article:-
Nair Sindhu1*, Bhat Kishore2, Nayak Ramakant3, Kotrashetti Vijayalakshmi4 & Babji Deepa5
Affiliation:-
1Postgraduate student, 3Professor and Head,4Reader, 5Senior lecturer,Department of Oral Pathology and Microbiology, 2Professor and Head,Department of Microbiology, Maratha Mandal’s NGH Institute of Dental Sciences and Research Centre.Near K.S.R.P.Ground, R.S.No.47/2, Bauxite Road, Belgaum.( Karnataka), India.
Abstract:
Introduction: Mutans streptococci (MS) and Lactobacilli are well known as cariogenic oral bacteria. MS has primarily been linked with initial caries development and lactobacilli with the progression of the caries lesion. Recent research suggests that even though lactobacilli have a role in progression of dental caries, they may also act as antimicrobial agents in the oral cavity.
Aim: To assess the relationship between MS and Lactobacillus in caries-free and high caries risk individuals.
Materials & Methods: 60 subjects (Group A – 30 caries free, Group B - 30 high caries risk individuals) in the age group of 16-25 years were considered for the study. Caries-free subjects were with a DMFT = 0, while those in the high risk group had a DMFT ≥ 3 with atleast 1 active carious lesion at the time of clinical examination. Plaque samples were collected and then cultured on Mann Rogosa Sharpe agar for Lactobacilli screening and on Mitis Salivarius Bacitracin agar for MS. Samples which were positive for both MS and lactobacillus were further cultured together. The interference capacity of Lactobacillus was then checked. Statistical analysis was done using Chi square test and Spearman rank correlation coefficient.
Results: On primary culture, Group A individuals were colonized predominantly by MS while those of Group B were colonized by both micro-organisms. On co-culturing, inhibitory effect was observed only in 1 case in Group A, while in Group B, inhibitory effect was observed in 15 cases and 1 case showed absence of inhibition. Statistically significant correlation between DMF and presence of lactobacillus was also found.
Conclusion: Our study demonstrates that lactobacillus has an inhibitory effect on MS group in vitro. Slight to complete inhibition was observed in the high risk caries individuals, while caries-free individuals did not show very specific results.
Key Words: Caries; Inhibition; Lactobacilli; Mutans streptococci.
References:
1.Takahashi N, Nyvad B. The Role of Bacteria in the Caries Process: Ecological Perspectives . J Dent Res 2011; 90(3):294-303.
2.Simark-Mattsson C, Emilson C-G, Grahn Hakansson E, Jacobsson C, Roos K, Holm S. Lactobacillus-mediated interference of mutans streptococci in caries-free vs. caries-active subjects . Eur J Oral Sci 2007; 115: 308–314
3.Lembo FL, Longo PL, Ota-Tsuzuki C, Rodrigues CRMD, Mayer MPA. Genotypic and phenotypic analysis of Streptococcus mutans from different oral cavity sites of caries-free and caries-active children.Oral Microbiol Immunol 2007: 22: 313–9.
4.Kohler B, Krasse B. Human strains of mutans streptococci show different cariogenic potential in the hamster model. Oral Microbiol Immunol 1990: 5: 177–80.
5.Phattarataratip E, Olson B, Broffitt B, Qian F, Brogden KA, Drake DR, Levy SM, Banas JA. Streptococcus mutans strains recovered from caries-active or caries-free individuals differ in sensitivity to host antimicrobial peptides. Molecular Oral Microbiology 2011; 26 : 187–99.
6.Ahumada MC, Bru E, Colloca ME, López ME, Nader-Macías ME. Evaluation and comparison of lactobacilli characteristics in the mouths of patients with or without cavities. Journal of Oral Science 2003;45(1):1-9.
7.Chuang L, Huang C, Ou-Yang L, Lin S. Probiotic Lactobacillus paracasei effect on cariogenic bacterial flora.. Clin Oral Invest 2011; 15:471–6.
8.Hasslöf P, Hedberg M, Twetman S, Stecksén-Blicks C. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli - an in vitro study. BMC Oral Health 2010; 10:18.
9.Soderling EM, Marttinen AM, Haukioja AL. Probiotic Lactobacilli Interfere with Streptococcus mutans Biofilm Formation In Vitro. Curr Microbiol 2011; 62:618–22
10.Wolff D, Frese C, Maier-Kraus T, Krueger T, Wolff B .Bacterial Biofilm Composition in Caries and Caries-Free Subjects. Caries Res 2013;47:69–77
11.Kneist S, Kubeiziel H, Willershausen B. Modeling of S mutans and A naeslundii acid production in vitro with caries incidence of low- and high-risk children Quintessence Int 2012;43:413–420)
12.Keller MK, Hasslöf P, Stecksén-Blicks C, Twetman S. Co-Aggregation And Growth Inhibition Of Probiotic Lactobacilli And Clinical Isolates Of Mutans Streptococci: An In Vitro Study . Acta Odontologica Scandinavica, 2011; Early Online, 1–6
13.Zhu Y, Xiao L, Shen D, Hao Y. Competition between yogurt probiotics and periodontal pathogens in vitro. Acta Odontol Scand 2010;68:261–8.
14.Chung J, Ha ES, Park HR, Kim S. Isolation and characterization of Lactobacillus species inhibiting the formation of Streptococcus mutans biofilm. Oral Microbiol Immunol 2004; 19(3): 214-216
15.Stecksen-Blicks C, Sjostrom I, Twetman S. Effect of longterm consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: a cluster-randomized study. Caries Res 2009; 43:374–81.
16.James SM, Tagg JR. A search within the Genera Streptococcus, Enterococcus and Lactobacillus for Organisms inhibitory to Mutans Streptococci. Microbial Ecology In Health And Disease. 1988; 1: 153-62.
17.Koll-Klais P, Mandar R, Leibur E, Marcotte H, Hammarstrom L, Mikelsaar M. Oral lactobacilli in chronic periodontitis and periodontal health: species composition and antimicrobial activity. Oral Microbiol Immunol 2005; 20: 354–61.
18.Corby PM, Bretz WA, Hart TC, Schork NJ, Wessel J, Lyons-Weiler J, and Paster BJ. Heritability of Oral Microbial Species in Caries-Active and Caries-Free Twins Twin Res Hum Genet. 2007 December ; 10(6): 821–8.
Article citation:-
Nair Sindhu et al. Effect of Lactobacillus on Mutans Streptococcus in caries-free and high caries risk individuals. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) 2013 June; 31(31): 1192-1198.
Copyright © 2013 Nair Sindhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Research article:-
Saurabh K. Deo1*,Jasbir Singh2,Kuldip Sodhi2 & Rajesh Pandey3
Affiliations:-
1B.Sc.Biochemistry, Post-graduate (M. Sc. Medical Biochemistry) student, 2MD Biochemistry Professor,3MD Biochemistry Associate Professor, Department of Biochemistry, MM Institute of Medical Sciences and Research, Mullana, Ambala, Haryana (India)- 133203.
Abstract:
Background: The monitoring of glycemic control is essential to avoid the potentially severe complications of diabetes mellitus. Serum glycated albumin (GA) is an important tool in assessing short term (2-4 weeks) glycemic control of diabetic patients. The Indian Diabetes Risk Score (IDRS, predicting risk of diabetes) considers four risk factors: age, abdominal obesity, family history of diabetes and physical activity.
Aims: To evaluate the efficacy of serum GA for diagnosing diabetes mellitus.
Setting and design: 100 staff members of MMIMSR, Mullana, Ambala, Haryana, India.
Materials and methods: Serum GA was measured by enzymatic glycated serum protein method. For IDRS, assessment was done using a validated questionnaire.
Statistical analysis: Epi-Info version 6.
Results and conclusions: The AUC (area under curve) under ROC (Receiver Operating Characterstics) for GA was significantly lower than that for IDRS. Thus, IDRS is more accurate compared with serum GA for identifying diabetes mellitus.
Key Words:- Diabetes mellitus, glucose, glycated albumin, glycemic control, IDRS.
References:-
1.Powers AC. Diabetes Mellitus. In: Fauci AS, Brownwald E, Kasper DL, Hauser SL, Longo BL, Jameson JL, et al, editors. Harrison’s Principles of Internal Medicine. 17th edition. United States of America (NY); Mc Graw Hill Companies, Inc; 2008, p. 2275-2304.
2.International Diabetes Federation (IDF), Diabetes Atlas, Fifth edition; 2011.
3.Sauden CD, Herman WD, Sacks DB, Bergenstal RM, Edelman D, Davidson M. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinal Metab; 2008, 93:2447- 53.
4.Burtis CA, Ashwood ER. Tietz Text Book of Clinical Chemistry. 3rd edition: W.B. Saunders Company (Indian edition); 1999, p. 790-91.
5.Wild S, Roglic G, Green A, Sicref R, King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-53.
6.National Diabetes Information Clearinghouse, National Institute of Health (NIH), US Department of Health and Human Service (2008), NIH Publication No. 09-4642. Available from www.diabetes.niddk.nih.gov.
7.Peters AL, Davidson MB, Schriger DL, Hasselbad V. A clinical approach for the diagnosis of diabetes mellitus. An analysis using glycosylated hemoglobin levels: for the meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA 1996; 276 (15):1246-52.
8.Use of glycated hemoglobin (HbA1c) in the diagnosis of diabetes mellitus, World Health Organisation (2011).Available from http://www.who.int/cardiovascular_diseases/report-hba1c_2011.
9.Dolhofer R, Wieland OH. Increased glycosylation of serum albumin in diabetes mellitus. Diabetes 1980; 29:417-22.
10.Vardhan A, Prabha MRA, Shashidhar MK, Shankar N, Gupta S, Tripathy A. Value of Indian Diabetes Risk Score among medical students and its correlation with fasting plasma glucose, blood pressure and lipid profile. J Clin Diag Res 2012; 6(9):1528-30.
11.Gupta SK, Singh Z, Purty AJ, Kar M, Vedapriya D, Mahajan P, Cherian J. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med 2010; 35(3):396-9.
12.Kouauma T, Usami T, Yamakoshi M, Takahashi M. An enzymatic method for the measurement of glycated albumin in biological samples. Clin Chim Acta 2002; 324: 61-71.
13.Roohk HV, Zaidi AR. A review of glycated albumin as an intermediate glycation index for controlling diabetes. J Diabetes Sci Technol 2008; 2(6):1114-21.
14.Lee EY, Lee BW, Kim D, Lee YH, Kim KJ, Kang ES, et al. Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients. Acta Diabetol 2011; 48(2):167-72.
15.Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, Someya Y, et al. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta 2007; 382(1-2): 59-64.
16.Gao WG, Dong YH, Pang ZC, Nan HR, Wang SJ, Ren J, et al. A simple Chinese risk score for undiagnosed diabetes. Diabet Med 2010; 27(3):274-81.
Article citation:-
Saurabh K. Deo et al. The efficacy of glycated albumin for diagnosing diabetes mellitus in staff members of MMIMSR, Mullana, Ambala, India. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) 2013, June; 31(31): 1204-1208.
Copyright © 2013 Saurabh K. Deo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Case report:-
*1Premraj Jadhav,2Sharad Acharya & 3Ketaki A .Patil.
Affiliation:-
1Professor,2Senior lecturer,3Postgraduate student, Department of Prosthodontics, Tatyasaheb Kore Dental College and Research Centre, New Paragon, Dist. Kolhapur- 416137,India.
Abstract: -
The problem of stability and retention of mandibular complete dentures is far from a solution that is universally satisfactory, smaller the number of mandibular teeth that remain, the more thoughtfully these teeth should be treated. Overdenture serves as the conservative prosthodontic treatment option in such cases. Also the retention and stability of such prosthesis is greatly enhanced by a bar connecting the abutments. Custom bar supported overdenture is a good alternative treatment modality because of its improved retention, stability, better chewing efficiency and also decrease in alveolar bone resorption. On the other hand, the immediate denture therapy for replacement of anterior missing teeth is expected and frequently demanded by appearance conscious people. The immediate denture enables them to engage in social activities and maintains physical and social well being of the patient. This case report presents the management of a patient with a bar retained mandibular overdenture opposing maxillary interim immediate denture.
Key Words:- Overdenture, bar joint,immediate denture, attachment.
References:
1.Tushar R, Suhasini J N. Rhabilitation of an edentulous patient with overdenture using magnetic attachments- A Case Report JIDA 2012; 6(2):142-4.
2.Harold W. Preiskel. Precision Attachments in Prosthodontics. Vol 1 Quintessence publishing: Co. 1984.
3.Thayer H.H, Caputo A.A. Occlusal force transmission by overdenture attachments.J Prosthet Dent 1979; 41: 266-71.
4.Morrow RM. Handbook of immediate overdentures. St. Louis: Mosby;1978:48.
5.Eugen J. Dolder, Dr.Med. Dent The bar joint mandibular denture. J Prosthet Dent 1961;11:689-707.
6.Sherring LM, Martin P : Attachments for prosthetic dentistry : Introduction and application. Quintessence publishing: 1st ed.
Article citation:-
Premraj Jadhav, Sharad Acharya & Ketaki A .Patil. Bar retained mandibular overdenture opposing maxillary complete immediate denture - A Case Report. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) 2013 June; 31(31): 1209-1213.
Copyright © 2013 Cemil Kavalci et al. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.